sudarshan chemical industries ltd - nse...sudarshan chemical industries ltd (sudarshan) reported...
TRANSCRIPT
© CRISIL Limited. All Rights Reserved.
Enhancing investment decisions
Q2FY12 Result Update
Sudarshan Chemical Industries Ltd
© CRISIL Limited. All Rights Reserved.
Explanation of CRISIL Fundamental and Valuation (CFV) matrix
The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis of an investment making process –
Analysis of Fundamentals (addressed through Fundamental Grade) and Analysis of Returns (Valuation Grade) The fundamental
grade is assigned on a five-point scale from grade 5 (indicating Excellent fundamentals) to grade 1 (Poor fundamentals) The
valuation grade is assigned on a five-point scale from grade 5 (indicating strong upside from the current market price (CMP)) to
grade 1 (strong downside from the CMP).
CRISIL Fundamental Grade
Assessment CRISIL Valuation Grade
Assessment
5/5 Excellent fundamentals 5/5 Strong upside (>25% from CMP)
4/5 Superior fundamentals 4/5 Upside (10-25% from CMP)
3/5 Good fundamentals 3/5 Align (+-10% from CMP)
2/5 Moderate fundamentals 2/5 Downside (- 10-25% from CMP)
1/5 Poor fundamentals 1/5 Strong downside (<-25% from CMP)
Analyst Disclosure
Each member of the team involved in the preparation of the grading report, hereby affirms that there exists no conflict of interest
that can bias the grading recommendation of the company. Additional Disclosure
This report has been sponsored by NSE - Investor Protection Fund Trust (NSEIPFT). Disclaimer:
This Exchange-commissioned Report (Report) is based on data publicly available or from sources considered reliable by CRISIL
(Data). However, CRISIL does not guarantee the accuracy, adequacy or completeness of the Data / Report and is not responsible for
any errors or omissions or for the results obtained from the use of Data / Report. The Data / Report are subject to change without
any prior notice. Opinions expressed herein are our current opinions as on the date of this Report. Nothing in this Report constitutes
investment, legal, accounting or tax advice or any solicitation, whatsoever. The Report is not a recommendation to buy / sell or hold
any securities of the Company. CRISIL especially states that it has no financial liability, whatsoever, to the subscribers / users of this
Report. This Report is for the personal information only of the authorized recipient in India only. This Report should not be
reproduced or redistributed or communicated directly or indirectly in any form to any other person – especially outside India or
published or copied in whole or in part, for any purpose.
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 1
Sudarshan Chemical Industries Ltd Business impacted by demand slowdown
Fundamental Grade 4/5 (Superior fundamentals)
Valuation Grade 3/5 (CMP is aligned) Industry Diversified Chemicals
Fair Value Rs 670 CMP Rs 619
November 16, 2011
Sudarshan Chemical Industries Ltd (Sudarshan) reported Q2FY12 results which came below CRISIL Research’s expectations. Revenue and profitability were negatively impacted because of weakened end-market demand, rising raw material prices and high interest costs. Though revenue grew by 9% y-o-y (+18% q-o-q), it was lower than our expectations as the demand from end-markets such as paints and inks was pruned. EPS declined ~18% y-o-y to Rs 19.8. We lower our FY12 and FY13 estimates to reflect the weakened demand environment and revise our fair value estimate to Rs 670 from Rs 764. We retain our fundamental grade of 4/5. Q2FY12 result analysis
• Q2FY12 revenue of Rs 2,097 mn grew by 9% y-o-y (+18% q-o-q),
however was below our growth expectations. The growth was largely
impacted by the slowdown in the end-markets such as paints and inks,
both domestic and overseas. The traction in demand of high performance
pigments has slowed down and was below our expectations. Additionally,
average volume sales and sales realisation in agrochemicals declined y-o-y
that caused a drag on the overall growth.
• EBITDA margin of 12.4% declined 310 bps y-o-y because of rising raw
material costs, particularly for oil-based and metal-based raw materials,
which the company found difficult to pass on in the current environment.
• PAT margin declined ~215 bps y-o-y (+23 bps q-o-q) to 6.5% due to
EBITDA margin contraction and higher interest costs. EPS for Q2FY12 was
Rs 19.8 compared to Rs 24.1 in Q2FY11. Estimates are revised downwards to reflect weak environment
We lower our FY12 and FY13 estimates to reflect the slowdown in business momentum. Our FY12 and FY13 revenue estimates are reduced from Rs 8,059 mn and Rs 9,212 mn to Rs 7,659 mn and Rs 8,803 mn respectively. Simultaneously, our FY12 and FY13 EPS estimates are lowered from Rs 75.2 and Rs 87.1 to Rs 64.3 and Rs 69.7 respectively.
Valuations: Current market price is aligned
We continue to use the discounted cash flow method to value Sudarshan. Based on lowered estimates, we lower our fair value estimate to Rs 670 from Rs 764 per share. Consequently, valuation grade is changed to 3/5.
KEY FORECAST
(Rs mn) FY09 FY10 FY11 FY12E FY13E
Operating income 4,621 5,942 7,252 7,659 8,803
EBITDA 542 827 883 950 1,144
Adj PAT 120 411 389 445 483
Adj EPS-Rs 17.3 59.4 56.2 64.3 69.7
EPS growth (%) 151.9 243.6 (5.5) 14.5 8.4
Dividend yield (%) 8.7 3.7 2.3 2.7 2.9
RoCE (%) 20.6 31.7 24.0 18.7 19.9
RoE (%) 12.3 34.9 25.3 23.6 21.8
PE (x) 6.2 6.6 11.0 9.6 8.9
P/BV (x) 0.7 2.0 2.5 2.1 1.8
EV/EBITDA (x) 2.9 4.4 7.0 7.1 5.8
CMP: Current market price
Source: Company, CRISIL Research estimate
CFV MATRIX
KEY STOCK STATISTICS NIFTY 5092
NSE ticker SUDARSCHEM
Face value (Rs per share) 10
Shares outstanding (mn) 6.9
Market cap (Rs mn)/(US$ mn) 4,285/86
Enterprise value (Rs mn) /(US$ mn) 6,192/124
52-week range (Rs) (H/L) 804/600
Beta 0.6
Free float (%) 47.2
Avg daily volumes (30-days) 851
Avg daily value (30-days) (Rs mn) 0.6
SHAREHOLDING PATTERN
PERFORMANCE VIS-À-VIS MARKET
Returns
1-m 3-m 6-m 12-m
Sudarshan -12% -12% -21% -5%
NIFTY -1% 0% -9% -17%
ANALYTICAL CONTACT Chetan Majithia (Head) [email protected]
Abhijeet Singh [email protected]
Bhaskar Bukrediwala [email protected]
Client servicing desk
+91 22 3342 3561 [email protected]
1 2 3 4 5
1
2
3
4
5
Valuation Grade
Fu
nd
am
en
tal G
rad
e
Poor Fundamentals
ExcellentFundamentals
Str
on
gD
ow
nsid
e
Str
on
gU
psid
e52.8% 52.8% 52.8% 52.8%
0.01% 0.01% 0.01% 0.01%
3.69% 3.69% 3.69% 3.69%
43.5% 43.5% 43.5% 43.5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Dec-10 Mar-11 Jun-11 Sep-11
Promoter FII DII Others
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 2
Sudarshan Chemical Industries Ltd
Q2FY12 Result Summary (Rs mn) Q2FY12 Q1FY12 Q2FY11 q-o-q (%) y-o-y (%) H1FY12 H1FY11 y-o-y (%)
Net sales 2,097 1,783 1,922 17.6 9.1 3,879 3,493 11.1
Raw materials cost 1,205 975 1,056 23.6 14.1 2,180 1,904 14.5
Raw materials cost (% of net sales) 57.5% 54.7% 54.9% 278bps 254bps 56.2% 54.5% 168bps
Employees cost 129 131 146 (2.0) (11.9) 260 269 (3.1)
Other expenses 504 462 423 9.0 19.0 966 818 18.0
EBITDA 259 214 297 20.9 (12.8) 473 501 (5.7)
EBITDA margin 12.4% 12.0% 15.4% 34bps -310bps 12.2% 14.4% -216bps
Depreciation 43 38 33 13.1 30.9 80 66 21.4
EBIT 216 176 264 22.6 (18.2) 392.7 435.2 (9.8)
Interest and finance charges 59 42 28 41.5 107.3 100 51 96.6
Operating PBT 157 135 236 16.8 (33.3) 292 384 (23.9)
Other Income 38 23 9 64.4 349.0 61 16 281.9
PBT 196 158 245 23.8 (20.0) 354 400 (11.6)
Tax 59 46 78 28.3 (24.4) 105 123 (14.7)
PAT 137 112 167 21.9 (17.9) 249 278 (10.3)
Adj PAT 137 112 167 21.9 (17.9) 249 278 (10.3)
Adj PAT margin 6.5% 6.3% 8.7% 23bps -214bps 6.4% 7.9% -152bps
No of equity shares (mn) 6.9 6.9 6.9 6.9 6.9
Adj EPS (Rs) 19.8 16.2 24.1 22.0 (17.9) 36.1 40.2 (10.3)
Source: Company, CRISIL Research
Traction in demand for pigments below
expectations
PAT declined y-o-y due to higher interest costs
Source: Company, CRISIL Research Source: Company, CRISIL Research
Growth in pigments fell short of expectations Agrochemicals continue to drag overall growth
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
1,31
2
1,57
6
1,57
1
1,92
2
1,66
2
1,90
8
1,78
3
2,09
7
13.5 13.4 13.0
15.4
11.5 12.012.0 12.4
0
2
4
6
8
10
12
14
16
18
0
500
1,000
1,500
2,000
2,500
Q3FY
10
Q4FY
10
Q1FY
11
Q2FY
11
Q3FY
11
Q4FY
11
Q1FY
12
Q2FY
12
(%)(Rs mn)
Revenue EBITDA margin (RHS)
85 135 111 167 76 96 112 137
6.5
8.6
7.1
8.7
10.2
5.0
6.3
6.5
0
2
4
6
8
10
12
0
20
40
60
80
100
120
140
160
180
Q3F
Y10
Q4F
Y10
Q1F
Y11
Q2F
Y11
Q3F
Y11
Q4F
Y11
Q1F
Y12
Q2F
Y12
(%)(Rs mn)
PAT PAT margin (RHS)
1,1
86
1,6
60
1,2
82
1,5
98
1,5
29
1,8
03
1,5
30
1,8
07
14.613.1
16.4
18.4
14.312.5
16.315.3
0
2
4
6
8
10
12
14
16
18
20
0
250
500
750
1,000
1,250
1,500
1,750
2,000
Q3F
Y10
Q4F
Y10
Q1F
Y11
Q2F
Y11
Q3F
Y11
Q4F
Y11
Q1F
Y12
Q2F
Y12
(%)(Rs mn)
Revenue EBIT margin (RHS)
120 133 284 318 127 106 247 286
6.0
1.0
10.2
8.86.9
-1.8
2.5
11.3
-4
-2
0
2
4
6
8
10
12
0
50
100
150
200
250
300
350
Q3F
Y10
Q4F
Y10
Q1F
Y11
Q2F
Y11
Q3F
Y11
Q4F
Y11
Q1F
Y12
Q2F
Y12
(%)(Rs mn)
Revenue EBIT margin (RHS)
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 3
Sudarshan Chemical Industries Ltd
Share price movement Fair value movement since initiation
-indexed to 100
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
KEY DEVELOPMENTS
• The commissioning of Sudarshan’s captive power plant has been delayed
by three months to January 2012 as against the previous deadline of
September 2011. We believe commissioning of captive power plant will
enable the company to lower its power costs and thereby support its
margins.
• Sudarshan’s capacity expansion of organic and inorganic pigments is on
stream, however the commissioning will likely be delayed to January 2012
from the previous deadline of December 2011.
0
100
200
300
400
500
600
700
Jan-0
8
Mar-
08
Jun-
08
Sep
-08
Dec-
08
Mar-
09
Jun-
09
Sep
-09
Dec-
09
Mar-
10
May-
10
Aug-1
0
Nov-1
0
Feb-
11
May-
11
Aug-1
1
Nov-1
1
Sudarshan NIFTY
0
2
4
6
8
10
12
14
16
18
600
620
640
660
680
700
720
740
760
780
07-
Jun-
11
15-
Jun-
11
23-
Jun-
11
01-J
ul-1
1
11-J
ul-1
1
20-J
ul-1
1
28-J
ul-1
1
05-A
u g-1
1
16-A
ug-1
1
24-A
ug-1
1
05-S
ep-
11
13-S
ep-
11
21-S
ep-
11
29-S
ep-
11
10-O
ct-1
1
18-O
ct-1
1
26-O
ct-1
1
04-
Nov-1
1
('000)(Rs)
Total Traded Quantity (RHS) CRISIL Fair Value Sudarshan
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 4
Sudarshan Chemical Industries Ltd
EARNINGS ESTIMATES REVISED DOWNWARDS
FY12E FY13E
Particulars Unit Old New % change Old New % change
Revenues (Rs mn) 8,059 7,659 -5% 9,212 8,803 -4%
EBITDA (Rs mn) 1,112 950 -15% 1,317 1,144 -13%
EBITDA margin % 13.8 12.4 (140)bps 14.3 13.0 (130)bps
PAT (Rs mn) 520 445 -14% 603 483 -20%
PAT margin % 6.5 5.8 (64)bps 6.5 5.5 (106)bps
EPS Rs 75.2 65.5 -14% 87.1 69.7 -20%
Source: CRISIL Research
Reasons for changes in estimates Line item FY12 FY13
Revenues • Weakness in end-market demand from paints, inks
and cosmetics sectors, both overseas and domestic
• Paint companies such as Asian Paints have pruned
their orders during the current quarter
• The company expects Q3 demand environment to
remain similar to Q2 with marginal improvement
expected in Q4
• Traction in high-performance pigments has also
been lower than expectations
• Demand likely to improve in FY13 though expected
to remain weaker than our earlier expectations
EBITDA margins • Increasing raw material prices
• Inability to pass on the increase in raw material
costs in the current macro-economic environment
• Increasing raw material prices
• Lower-than-expected traction in high performance
chemicals
• Partially offset by captive power plant getting
commissioned.
PAT margins • EBITDA margin contraction
• Higher interest costs related to debt for capex and
working capital financing
• EBITDA margin contraction
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 5
Sudarshan Chemical Industries Ltd
VALUATION
We continue to use the discounted cash flow method to value Sudarshan. Based
on lowered estimates and the current business environment, we lower our fair
value estimate to Rs 670 from Rs 764. At this value, the implied P/E multiples
are 10x FY12 earnings estimate and 10x FY13 earnings estimate.
One-year forward P/E band One-year forward EV/EBITDA band
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
P/E – premium/discount to NIFTY P/E movement
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
CRISIL IER reports released on Sudarshan Chemical Industries Ltd
Date Nature of report
Fundamental
grade Fair value
Valuation
grade
CMP
(on the date of report)
07-Jun-10 Initiating coverage 4/5 Rs 764 3/5 Rs 760
24-Aug-11 Q1FY12 result update 4/5 Rs 764 3/5 Rs 723
16-Nov-11 Q2FY12 result update 4/5 Rs 670 3/5 Rs 619
* For detailed initiating coverage report please visit: www.ier.co.in CRISIL Independent Equity Research reports are also available on Bloomberg (CRI <go>) and Thomson Reuters.
0
200
400
600
800
1,000
1,200
Apr-
07
Jul-
07
Oct
-07
Jan-0
8
Apr-
08
Jul-
08
Oct
-08
Jan-0
9
Apr-
09
Jul-
09
Oct
-09
Jan-1
0
Apr-
10
Jul-
10
Oct
-10
Jan-1
1
Apr-
11
Jul-
11
Nov
-11
(Rs)
Sudarshan 2x 5x 8x 11x 14x
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
Apr-
07
Jul-
07
Oct
-07
Jan-0
8
Apr-
08
Jul-
08
Oct
-08
Jan-0
9
Apr-
09
Jul-
09
Oct
-09
Jan-1
0
Apr-
10
Jul-
10
Oct
-10
Jan-1
1
Apr-
11
Jul-
11
Nov
-11
(Rs mn)
EV 5x 6x 7x 8x
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
Apr
-07
Jul-
07
Oct
-07
Jan-
08
Apr
-08
Jul-
08
Oct
-08
Jan-
09
Apr
-09
Jul-
09
Oct
-09
Jan-
10
Apr
-10
Jul-
10
Oct
-10
Jan-
11
Apr
-11
Aug-
11
Nov
-11
Premium/Discount to NIFTY Median premium/discount to NIFTY
0
2
4
6
8
10
12
14
16
18
Apr-
07
Jul-
07
Oct
-07
Jan-0
8
Apr-
08
Jul-
08
Oct
-08
Jan-0
9
Apr-
09
Jul-
09
Oct
-09
Jan-1
0
Apr-
10
Jul-
10
Oct
-10
Jan-1
1
Apr-
11
Jul-
11
Nov-1
1
(Times)
1yr Fwd PE (x) Median PE
+1 std dev
-1 std dev
© CRISIL Limited. All Rights Reserved. CRISIL RESEARCH | 6
Sudarshan Chemical Industries Ltd
FINANCIALS
Note: All ratios are computed on Adj PAT
Source: Company, CRISIL Research estimate
Income statement Balance Sheet
(Rs mn) FY09 FY10 FY11 FY12E FY13E (Rs mn) FY09 FY10 FY11 FY12E FY13E
Operating income 4,621 5,942 7,252 7,659 8,803 Liabilities
EBITDA 542 827 883 950 1,144 Equity share capital 69 69 69 69 69
EBITDA margin 11.7% 13.9% 12.2% 12.4% 13.0% Reserves 944 1,278 1,660 1,971 2,309
Depreciation 136 145 144 168 207 Minorities - - - - -
EBIT 406 683 739 782 938 Net worth 1,013 1,347 1,729 2,040 2,378
Interest 183 75 123 217 215 Convertible debt - - - - -
Operating PBT 222 608 617 565 722 Other debt 933 1,018 2,055 2,555 2,455
Other income (7) 2 6 90 9 Total debt 933 1,018 2,055 2,555 2,455
Exceptional inc/(exp) - - 93 - - Deferred tax liability (net) 69 59 121 121 121
PBT 215 610 716 655 731 Total liabilities 2,015 2,424 3,905 4,716 4,954
Tax provision 95 199 234 210 249 Assets
Minority interest - - - - - Net fixed assets 912 962 1,434 1,816 2,215
PAT (Reported) 120 411 482 445 483 Capital WIP 52 112 388 215 215
Less: Exceptionals - - 93 - - Total fixed assets 964 1,074 1,822 2,031 2,430
Adjusted PAT 120 411 389 445 483 Investments 0 0 0 0 0
Current assets
Ratios Inventory 719 855 1,180 1,259 1,326
FY09 FY10 FY11 FY12E FY13E Sundry debtors 762 1,232 1,701 1,784 1,929
Growth Loans and advances 190 173 275 766 440
Operating income (%) 15.5 28.6 22.0 5.6 14.9 Cash & bank balance 91 103 148 89 113
EBITDA (%) 80.1 52.7 6.7 7.5 20.5 Marketable securities 3 23 3 3 3
Adj PAT (%) 151.9 243.6 (5.5) 14.5 8.4 Total current assets 1,766 2,386 3,307 3,901 3,812
Adj EPS (%) 151.9 243.6 (5.5) 14.5 8.4 Total current liabilities 715 1,059 1,244 1,236 1,307
Net current assets 1,051 1,327 2,063 2,665 2,504
Profitability Intangibles/Misc. expenditure - 24 20 20 20
EBITDA margin (%) 11.7 13.9 12.2 12.4 13.0 Total assets 2,015 2,424 3,905 4,716 4,954
Adj PAT Margin (%) 2.6 6.9 5.4 5.8 5.5
RoE (%) 12.3 34.9 25.3 23.6 21.8 Cash flow
RoCE (%) 20.6 31.7 24.0 18.7 19.9 (Rs mn) FY09 FY10 FY11 FY12E FY13E
RoIC (%) 15.8 23.7 17.6 18.5 15.3 Pre-tax profit 215 610 623 655 731
Total tax paid (120) (209) (172) (210) (249)
Valuations Depreciation 136 145 144 168 207
Price-earnings (x) 6.2 6.6 11.0 9.6 8.9 Working capital changes 104 (244) (711) (661) 184
Price-book (x) 0.7 2.0 2.5 2.1 1.8 Net cash from operations 336 302 (116) (48) 874
EV/EBITDA (x) 2.9 4.4 7.0 7.1 5.8 Cash from investments
EV/Sales (x) 0.3 0.6 0.9 0.9 0.8 Capital expenditure (179) (278) (888) (377) (605)
Dividend payout ratio (%) 54.1 24.5 20.9 25.8 25.8 Investments and others 3 (20) 20 - -
Dividend yield (%) 8.7 3.7 2.3 2.7 2.9 Net cash from investments (176) (298) (868) (377) (605)
Cash from financing
B/S ratios Equity raised/(repaid) - - - - -
Inventory days 71 69 75 76 71 Debt raised/(repaid) (116) 85 1,036 500 (100)
Creditors days 49 63 61 55 50 Dividend (incl. tax) (65) (101) (101) (134) (145)
Debtor days 57 75 85 83 78 Others (incl extraordinaries) 23 23 93 - -
Working capital days 80 66 78 107 103 Net cash from financing (158) 8 1,029 366 (245)
Gross asset turnover (x) 1.7 2.1 2.3 2.1 2.1 Change in cash position 2 12 45 (59) 23
Net asset turnover (x) 5.3 6.3 6.1 4.7 4.4 Closing cash 91 103 148 89 113
Sales/operating assets (x) 4.9 5.8 5.0 4.0 3.9
Current ratio (x) 2.5 2.3 2.7 3.2 2.9 Quarterly financials
Debt-equity (x) 0.9 0.8 1.2 1.3 1.0 (Rs mn) Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12
Net debt/equity (x) 0.8 0.7 1.1 1.2 1.0 Net Sales 1,922 1,662 1,908 1,783 2,097
Interest coverage 2.2 9.1 6.0 3.6 4.4 Change (q-o-q) 22% -14% 15% -7% 18%
EBITDA 297 190 229 214 259
Per share Change (q-o-q) 45% -36% 20% -6% 21%
FY09 FY10 FY11 FY12E FY13E EBITDA margin 15.4% 11.5% 12.0% 12.0% 12.4%
Adj EPS (Rs) 17.3 59.4 56.2 64.3 69.7 PAT 167 170 96 112 137
CEPS 37.0 80.3 77.0 88.5 99.6 Adj PAT 167 76 96 112 137
Book value 146.4 194.6 249.7 294.8 343.6 Change (q-o-q) 50% -54% 26% 17% 22%
Dividend (Rs) 9.4 14.6 14.5 16.6 18.0 Adj PAT margin 8.7% 4.6% 5.0% 6.3% 6.5%
Actual o/s shares (mn) 6.9 6.9 6.9 6.9 6.9 Adj EPS 24.1 11.0 13.9 16.2 19.8
© CRISIL Limited. All Rights Reserved.
CRISIL Research Team
Senior Director
Mukesh Agarwal +91 (22) 3342 3035 [email protected]
Analytical Contacts Tarun Bhatia Director, Capital Markets +91 (22) 3342 3226 [email protected]
Prasad Koparkar Head, Industry & Customised Research +91 (22) 3342 3137 [email protected]
Chetan Majithia Head, Equities +91 (22) 3342 4148 [email protected]
Jiju Vidyadharan Head, Funds & Fixed Income Research +91 (22) 3342 8091 [email protected]
Ajay D'Souza Head, Industry Research +91 (22) 3342 3567 [email protected]
Ajay Srinivasan Head, Industry Research +91 (22) 3342 3530 [email protected]
Sridhar C Head, Industry Research +91 (22) 3342 3546 [email protected]
Manoj Mohta Head, Customised Research +91 (22) 3342 3554 [email protected]
Sudhir Nair Head, Customised Research +91 (22) 3342 3526 [email protected]
Business Development
Vinaya Dongre Head, Industry & Customised Research +91 (22) 33428025 [email protected]
Ashish Sethi Head, Capital Markets +91 (22) 33428023 [email protected]
CRISIL’s Equity Offerings
The Equity Group at CRISIL Research provides a wide range of services including:
Independent Equity Research
IPO Grading
White Labelled Research
Valuation on companies for use of Institutional Investors, Asset Managers, Corporate
Other services by the Research group include
Funds & Fixed Income Research
Mutual fund rankings
Wealth Tracking and Financial Planning tools for asset managers, wealth managers and IFAs
Valuation for all debt instruments
Developing and maintaining debt and hybrid indices
Consultancy and research support to retirement funds
Industry & Customized Research
Provide comprehensive research coverage across 65 sectors
Customised research on market sizing, demand modelling and entry strategies
Customised research content for Information Memorandum and Offer Documents
© CRISIL Limited. All Rights Reserved.
Head Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400 076 Phone : 91-22-3342 3000 Web: www.crisil.com Download reports from: www.ier.co.in
Ahmedabad / Mumbai Vishal Shah - Manager, Business Development Email : [email protected] I Phone : 9820598908 Bengaluru Gayathri Ananth – Senior Manager, Business Development Email : [email protected] I Phone : 9886498175 Chennai / Hyderabad Kaliprasad Ponnuru - Manager, Business Development Email : [email protected] I Phone : 9642004668
Delhi Arjun Gopalkrishnan - Manager, Business Development Email :[email protected] I Phone : 9833364422 Kolkata Priyanka Agarwal - Manager, Business Development Email : [email protected] I Phone : 9903060685 Mumbai / Pune Vivek Tandon - Manager, Business Development Email : [email protected] I Phone : 9903060685
Vinaya Dongre – Head, Business Development
Email : [email protected] I Phone : 9920225174
Sagar Sawarkar – Senior Manager, Business Development Email : [email protected] I Phone : 9821638322
Regional Contacts:
To know more about CRISIL IER, please contact our team members:
Ashish Sethi – Head, Business Development
Email : [email protected] I Phone : 9920807575
About CRISIL Limited
CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are
India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks
and leading corporations.
About CRISIL Research CRISIL Research is the country’s largest independent and integrated research house with strong domain expertise
on Indian economy, industries and capital markets. We leverage our unique research platform and capabilities to
deliver superior perspectives and insights to over 1200 domestic and global clients, through a range of research
reports, analytical tools, subscription products and customised solutions.
Head Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400 076 Phone : 91-22-3342 3000 Web: www.crisil.com Download reports from: www.ier.co.in
Head Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400 076 Phone : 91-22-3342 3000 Web: www.crisil.com Download reports from: www.ier.co.in
Ahmedabad / Mumbai Vishal Shah - Manager, Business Development Email : [email protected] I Phone : 9820598908 Bengaluru Gayathri Ananth – Senior Manager, Business Development Email : [email protected] I Phone : 9886498175 Chennai / Hyderabad Kaliprasad Ponnuru - Manager, Business Development Email : [email protected] I Phone : 9642004668
Delhi Arjun Gopalkrishnan - Manager, Business Development Email :[email protected] I Phone : 9833364422 Kolkata Priyanka Agarwal - Manager, Business Development Email : [email protected] I Phone : 9903060685 Mumbai / Pune Vivek Tandon - Manager, Business Development Email : [email protected] I Phone : 9903060685
Ashish Sethi – Head, Business Development Email : [email protected] I Phone : 9920807575
Regional Contacts:
To know more about CRISIL IER, please contact our team members:
Sagar Sawarkar – Senior Manager, Business Development
Email : [email protected] I Phone : 9821638322
Head Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400 076 Phone : 91-22-3342 3000 Web: www.crisil.com Download reports from: www.ier.co.in